We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Beauty Health Company (SKIN) Stock Jumps 5.6%: Will It Continue to Soar?
Read MoreHide Full Article
The Beauty Health Company (SKIN - Free Report) shares ended the last trading session 5.6% higher at $14.61. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 0.9% gain over the past four weeks.
The Beauty Health Company scored a strong price rise on optimism surrounding the company’s expansion of partnership with Murad, a renowned clinical skincare brand, to launch the new Clarifying Booster for HydraFacial. The new booster has been formulated to particularly address breakouts and troublesome skin, as part of a customized HydraFacial experience. HydraFacial first teamed up with Murad in 2021, and currently offers the Murad Retinol Booster, the Murad Vita-C Booster and the new Clarifying Booster.
This company is expected to post quarterly earnings of $0.01 per share in its upcoming report, which represents a year-over-year change of -87.5%. Revenues are expected to be $86.06 million, up 29.4% from the year-ago quarter.
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.
For The Beauty Health Company, the consensus EPS estimate for the quarter has been revised 50% higher over the last 30 days to the current level. And a positive trend in earnings estimate revision usually translates into price appreciation. So, make sure to keep an eye on SKIN going forward to see if this recent jump can turn into more strength down the road.
The Beauty Health Company is a member of the Zacks Medical Services industry. One other stock in the same industry, Avantor, Inc. (AVTR - Free Report) , finished the last trading session 1% higher at $31.60. AVTR has returned -1.5% over the past month.
Avantor, Inc.'s consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.38. Compared to the company's year-ago EPS, this represents a change of +8.6%. Avantor, Inc. currently boasts a Zacks Rank of #3 (Hold).
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Beauty Health Company (SKIN) Stock Jumps 5.6%: Will It Continue to Soar?
The Beauty Health Company (SKIN - Free Report) shares ended the last trading session 5.6% higher at $14.61. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 0.9% gain over the past four weeks.
The Beauty Health Company scored a strong price rise on optimism surrounding the company’s expansion of partnership with Murad, a renowned clinical skincare brand, to launch the new Clarifying Booster for HydraFacial. The new booster has been formulated to particularly address breakouts and troublesome skin, as part of a customized HydraFacial experience. HydraFacial first teamed up with Murad in 2021, and currently offers the Murad Retinol Booster, the Murad Vita-C Booster and the new Clarifying Booster.
This company is expected to post quarterly earnings of $0.01 per share in its upcoming report, which represents a year-over-year change of -87.5%. Revenues are expected to be $86.06 million, up 29.4% from the year-ago quarter.
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.
For The Beauty Health Company, the consensus EPS estimate for the quarter has been revised 50% higher over the last 30 days to the current level. And a positive trend in earnings estimate revision usually translates into price appreciation. So, make sure to keep an eye on SKIN going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
The Beauty Health Company is a member of the Zacks Medical Services industry. One other stock in the same industry, Avantor, Inc. (AVTR - Free Report) , finished the last trading session 1% higher at $31.60. AVTR has returned -1.5% over the past month.
Avantor, Inc.'s consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.38. Compared to the company's year-ago EPS, this represents a change of +8.6%. Avantor, Inc. currently boasts a Zacks Rank of #3 (Hold).